| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2009 | US7560123 Compositions and methods for nutrition supplementation |
| 07/14/2009 | US7560122 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 07/14/2009 | US7560121 fluphenazine dihydrochloride-containing transdermal therapeutic system (TTS) which releases at least desired active agent to the human skin, comprises an enhancer and has a skin-facing pressure-sensitive adhesive layer based on polymers which are pure hydrocarbons; treating schizophrenia and psychoses |
| 07/14/2009 | US7560120 Using citric acid esters or ethers |
| 07/14/2009 | US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 07/14/2009 | US7560100 Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases |
| 07/14/2009 | US7560098 Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostabilizing properties, compositions containing same, and methods of using the same |
| 07/14/2009 | CA2649740A1 Therapies for cognition and learning enhancement |
| 07/14/2009 | CA2543665C Cci-779 for treating mantle cell lymphoma |
| 07/14/2009 | CA2533369C Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| 07/14/2009 | CA2532818C (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 07/14/2009 | CA2521133C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha.-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/14/2009 | CA2503718C Use of serotonin receptor antagonists for the treatment of sleep apnea |
| 07/14/2009 | CA2472392C Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/14/2009 | CA2439858C Graft rejection suppressors |
| 07/14/2009 | CA2439222C Identification of partial agonists of the a2a adenosine receptor |
| 07/14/2009 | CA2429639C Stable azithromycin monohydrate |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/14/2009 | CA2402988C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 07/14/2009 | CA2390933C Oral solid preparation comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide |
| 07/14/2009 | CA2390092C Solid dispersion pharmaceutical formulations |
| 07/14/2009 | CA2386790C Chromium-histidine complexes as nutrient supplements |
| 07/14/2009 | CA2379841C Biphenyl derivatives, the preparation thereof and their use as medicaments |
| 07/14/2009 | CA2366754C Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 07/14/2009 | CA2360776C Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders |
| 07/14/2009 | CA2338090C Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies |
| 07/14/2009 | CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity |
| 07/14/2009 | CA2331410C Methods for treating diabetes by inhibiting gdf-8 |
| 07/14/2009 | CA2306560C Topical antifungal composition |
| 07/14/2009 | CA2262972C Compositions of plant carbohydrates as dietary supplements |
| 07/14/2009 | CA2254548C Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/14/2009 | CA2183543C Sexual steroid-containing transdermal therapeutic systems |
| 07/13/2009 | CA2711728A1 Novel imidazolinylmethyl aryl sulfonamides |
| 07/12/2009 | CA2712010A1 Solid pharmaceutical dosage form |
| 07/11/2009 | CA2639285A1 Solid dosage formulations containing weight-loss drugs |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086558A1 Improved compositions and methods for the delivery of nucleic acids |
| 07/09/2009 | WO2009086526A2 Methods for enhancing muscle performance and tone |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086438A2 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086437A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086429A1 Soluble epoxide hydrolase inhibitors |
| 07/09/2009 | WO2009086426A2 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
| 07/09/2009 | WO2009086303A2 Method for altering the lifespan of eukaryotic organisms |
| 07/09/2009 | WO2009086277A1 Tetrasubstituted benzenes |
| 07/09/2009 | WO2009086264A1 Benzofuropyrimidinones as protein kinase inhibitors |
| 07/09/2009 | WO2009086204A2 Methods for treating neuropsychiatric conditions |
| 07/09/2009 | WO2009086201A1 2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents |
| 07/09/2009 | WO2009086192A1 Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents |
| 07/09/2009 | WO2009086139A1 Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 07/09/2009 | WO2009086138A1 Benzimidazole compounds |
| 07/09/2009 | WO2009086137A1 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 07/09/2009 | WO2009086130A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | WO2009086129A1 Pyrazolo [1,5-a] pyrimidine compounds |
| 07/09/2009 | WO2009086123A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | WO2009086108A1 Stable elsamitrucin salt formulations |
| 07/09/2009 | WO2009086097A1 Intraocular irrigating solutions comprising histidine and methods for treating corneal edema |
| 07/09/2009 | WO2009086096A2 Therapeutic use of carboxyl ester lipase inhibitors |
| 07/09/2009 | WO2009086076A2 Particles for injection and processes for forming the same |
| 07/09/2009 | WO2009086073A1 Stabilized glycerophosphate-containing surgical irrigating solution |
| 07/09/2009 | WO2009086055A1 Enhancing photostabilization of oxymetazoline |
| 07/09/2009 | WO2009086044A1 Prolyl hydroxylase inhibitors |
| 07/09/2009 | WO2009086041A1 Herbicidal pyridazinone derivatives |
| 07/09/2009 | WO2009085988A1 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | WO2009085983A1 5-anilinoimidazopyridines and methods of use |
| 07/09/2009 | WO2009085980A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 07/09/2009 | WO2009085978A1 Bridged carbocyclic oxime hepatitis c virus serine protease inhibitors |
| 07/09/2009 | WO2009085972A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | WO2009085945A1 Benzothiazole and benzoxazole derivatives and methods of use |
| 07/09/2009 | WO2009085913A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS |
| 07/09/2009 | WO2009085888A1 Composition containing a polyorganosiloxane polymer and a polar modified wax |
| 07/09/2009 | WO2009085880A2 C-21 thioethers as glucocorticoid receptor agonists |
| 07/09/2009 | WO2009085879A2 C20-c21 substituted glucocorticoid receptor agonists |
| 07/09/2009 | WO2009085847A1 Tetrahydroindoles having sphingosine-1-phosphate receptor activity |
| 07/09/2009 | WO2009085832A2 Manufacture of tablet |
| 07/09/2009 | WO2009085828A2 Quinine sulfate polymorphs, processes of preparing, compositions and uses thereof |
| 07/09/2009 | WO2009085766A2 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 07/09/2009 | WO2009085695A1 Treatment or prevention of skin injury due to exposure to ultraviolet light |
| 07/09/2009 | WO2009085659A1 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide |
| 07/09/2009 | WO2009085637A1 Amorphous metaxalone and amorphous dispersions thereof |
| 07/09/2009 | WO2009085584A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
| 07/09/2009 | WO2009085475A1 Method for detection and treatment of aneurysms |
| 07/09/2009 | WO2009085360A2 Citreamicin antibiotic with a sugar residue |
| 07/09/2009 | WO2009085359A2 Citreamicin antibiotic isolated from nocardia |
| 07/09/2009 | WO2009085314A1 Compositions and methods for treating diseases of the nail |
| 07/09/2009 | WO2009085310A1 Extended-release pharmaceutical compositions containing zolpidem |
| 07/09/2009 | WO2009085267A1 Antiviral compounds |
| 07/09/2009 | WO2009085262A1 Method of treating cancer with immunomodulatory compounds and igg |
| 07/09/2009 | WO2009085256A1 Anti-hiv compounds |
| 07/09/2009 | WO2009085236A2 Compositions and methods of using substance p. analogs |
| 07/09/2009 | WO2009085230A1 Inhibitors of pi3 kinase |
| 07/09/2009 | WO2009085226A2 Inhibitors of cdc2-like kinases (clks) and methods of use thereof |
| 07/09/2009 | WO2009085198A2 Combination of metformin r-(+)-lipoate and antiobesity agents for the treatment of diabetic hyperglycemia and diabetic complications |
| 07/09/2009 | WO2009085185A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |